HEPATITIS C MAY NOT PROGRESS AS OFTEN AS BELIEVED

The chances of eventually developing cirrhosis or another serious liver
disease from hepatitis C virus (HCV) may be lower than many experts
believe, according to a computer simulation based on US liver disease
statistics.

"The news would be better if we could reliably predict which patients will
and which will not progress quickly, which is not possible at this time,"
said study coauthor Dr. Joshua A. Salomon of the World Health
Organization. As such, doctors must still face the difficult decision of
when to put which patients on potentially toxic medications to slow the
infection's damage to the liver, Salomon said.

Salomon added that many previous estimates of when HCV patients can expect
to develop liver disease have been based on patients who have already been
diagnosed with liver disease. Patients who come to doctors because they are
sick will most likely progress more quickly, the researcher noted, while
those who are healthy enough to remain in the general population may stay
disease-free for longer periods.

In the current study, "Empirically Calibrated Model of Hepatitis C Virus
Infection in the United States," published in the Oct. 15 American Journal
of Epidemiology (2002; 156:761-773), Salomon and colleagues designed a
computer simulation of the US population that could predict when different
HCV patients would develop liver disease, then tweaked it until its results
matched current data registries and national surveys. The investigators
discovered that the model that best matched what is seen in real HCV
patients was one in which they had a relatively low rate of developing
liver disease.

"Because the disease progresses so slowly in some people, they are likely
to reach an old age and die from something else before their hepatitis C
infections ever progress to serious liver disease such as cirrhosis or
cancer," Salomon explained. For example, past studies have suggested that
people infected with the virus in their 20s might develop cirrhosis
anywhere from 20 to 38 years later. The new calculation suggested that half
of men infected at age 25 would develop cirrhosis within the next 46 years
and that fewer than 30 percent of women infected at this age "would ever
develop cirrhosis," according to the report.

However, each individual is different, Salomon noted. "The fact that many
infected people will not progress to cirrhosis should be one of several
important considerations in individual decisions about whether or not to
start treatment, along with the costs, potential side effects, and limited
effectiveness of available therapies," said Salomon.